Loading Events


AHHC of NC 2 Day Workshop

Speaker(s): Melinda A. Gaboury, CEO

Category: Speaking Engagement

  • This event has passed.
AHHC of NC 2 Day Workshop Nov 06 - Nov 07, 2019
Hosted by

About the Event

Day 1 | Wednesday, November 6, 2019 | Patient-Driven Groupings Model (PDGM)

PDGM dramatically impacts agency operations, processes, and performance. Learn strategies and processes to prepare. Topics will focus on
best episode management and process improvement practices, including referral, intake, and scheduling processes to help you more tightly
manage care within the shorter 30-day payment period.

Day 2 | Thursday, November 7, 2019 | Hospice Reimbursement

Changes to the Medicare Hospice Reimbursement have occurred over the past few years and continue. Do you know that you are getting
paid correctly? Be among the elite group of billers that are current on all Hospice Medicare billing regulations. Billing is a very critical part
of hospice reimbursement. This workshop will lay a concrete foundation for hospice billers, as well as, any hospice staff that need to more
effectively understand the Medicare regulations. This workshop will include field by field on Notice of Election and claim forms and
sequential billing requirements. The Routine High & Low rates and SIA payments will be covered. A review of the Hospice Levels of Care
and issues surrounding the documentation toward those levels of care will be discussed. The session will review the regulations for billing
all hospice services, face-to-face encounters and additionally home health providing care while a patient is on service with hospice. The
workshop will conclude with highlights from the most recent Hospice PEPPER Reports. If you are part of the billing cycle in hospice this
workshop is a must.

Program Highlights

• Review the impact of PDGM on agency operations
• Discuss the importance of ICD-10 Coding, timely OASIS review, and clinical documentation
• Review strategic planning for implementation of clinical episode management best practices
• Review the complexity of determining LUPA thresholds and LUPA prevention
• Review therapy utilization practices, discuss methods to evaluate current practices and implement changes for PDGM